Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study-Reference-Cited by-同舟云学术

Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study

Published:2018-04-26 Issue:3 Volume:5 Page:273-282
ISSN:2330-1619
Container-title:Movement Disorders Clinical Practice
language:en
Short-container-title:Mov Disord Clin Pract

Author:

Jankovic Joseph¹,Truong Daniel²,Patel Atul T.³,Brashear Allison⁴,Evatt Marian⁵,Rubio Roman G.⁶,Oh Chad K.⁶,Snyder Daniel⁶,Shears Gill⁷,Comella Cynthia⁸

Affiliation:

1. Parkinson's Disease Center and Movement Disorders Clinic; Department of Neurology, Baylor College of Medicine; Houston TX

2. The Parkinson's and Movement Disorder Institute; Fountain Valley CA

3. Kansas City Bone & Joint Clinic; Overland Park KS

4. Wake Forest Baptist Medical Center; Winston Salem NC

5. Acting Chief, Neurology Department of Veterans Affairs Medical Center, Atlanta, GA and Department of Neurology; Emory University; Atlanta GA

6. Revance Therapeutics, Inc.; Newark CA

7. Write on Target Ltd.; Leighton Buzzard UK

8. Rush University Medical Center; Chicago IL

Funder

Revance Therapeutics, Inc.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mdc3.12613/fullpdf

Reference20 articles.

1. Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin;Contarino;Front Neurol,2017

2. Botulinum toxin: State of the art;Jankovic;Mov Disord,2017

3. Striving for more good days: patient perspectives on botulinum toxin for the treatment of cervical dystonia;Poliziani;Patient Prefer Adherence,2016

4. Botulinum toxin therapy for cervical dystonia: the science of dosing;Evidente;Tremor Other Hyperkinet Mov (NY),2014

5. Injectable daxibotulinumtoxinA for the treatment of glabellar lines: a phase 2, randomized, dose-ranging, double-blind, multicenter comparison with onabotulinumtoxinA and placebo;Carruthers;Dermatol Surg,2017

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Non-Interchangeability of Botulinum Neurotoxin Products;Toxins;2024-06-10

2. Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia;Neurology;2024-02-27

3. Botulinum toxin treatment in parkinsonism;Journal of the Neurological Sciences;2024-01

4. A technology evaluation of the atypical use of a CPP-containing peptide in the formulation and performance of a clinical botulinum toxin product;Expert Opinion on Drug Delivery;2023-09-02

5. Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress;Biomedicines;2023-07-12